Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becotatug Vedotin Plus Pucotenlimab in Metastatic Colorectal Cancer
NCT07884188Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of becotatug vedotin, pucotenlimab in colorectal cancer (CRC), sponsored by Fudan University. Started Oct 2026; status: recruiting.
02
Drugs
becotatug vedotinpucotenlimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07884188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07884188.